I'm working on
2 months ago
Genome editing, nonviral delivery, liver cell therapy
About
Focuses on ex vivo genome editing and nonviral delivery for liver therapeutics. Develops electroporation workflows that maintain viability and improve engraftment, integrates hepatocyte transplantation, and validates clinical‑grade processes in preclinical metabolic liver disease models and disease models.
Partnering listings
Learn more
Sign up to view the full profile.
Explore areas of focus, current work, and collaboration capabilities.Already have an account? Sign in
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.